HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Snoeck Selected Research

Cidofovir (Vistide)

10/2018Treatment of intraurethral condylomata acuminata with surgery and cidofovir instillations in two immunocompromised patients and review of the literature.
2/2015Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.
5/2011Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary human renal cells.
10/2009Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study.
6/2007Dual infection with polyomavirus BK and acyclovir-resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipient.
12/2005Activities of acyclic nucleoside phosphonates against Orf virus in human and ovine cell monolayers and organotypic ovine raft cultures.
1/2005Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
8/2003Topical cidofovir (HPMPC) is an effective adjuvant to surgical treatment of anogenital condylomata acuminata.
11/2002Antivaccinia activities of acyclic nucleoside phosphonate derivatives in epithelial cells and organotypic cultures.
10/2001Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Snoeck Research Topics

Disease

10Infections
02/2015 - 02/2000
7Neoplasms (Cancer)
02/2015 - 02/2000
3Papilloma (Papillomatosis)
02/2015 - 02/2001
3Cytomegalovirus Retinitis
02/2015 - 11/2002
3Herpes Simplex
06/2007 - 03/2000
3Herpesviridae Infections (Herpesvirus Infection)
06/2001 - 01/2000
2Condylomata Acuminata (Genital Wart)
10/2018 - 08/2003
2Chronic Hepatitis B
02/2015 - 01/2005
2Chickenpox
01/2013 - 03/2004
2Uterine Cervical Dysplasia
10/2009 - 02/2000
2Carcinoma (Carcinomatosis)
01/2009 - 06/2008
2Leukemia
06/2008 - 05/2001
2Poxviridae Infections
01/2005 - 06/2004
2Acquired Immunodeficiency Syndrome (AIDS)
01/2005 - 10/2001
2Kaposi Sarcoma (Kaposi's Sarcoma)
02/2001 - 11/2000
1Latent Infection
04/2013
1Herpes Zoster
01/2013
1DNA Virus Infections
05/2011
1Hemorrhagic Cystitis
06/2007
1Contagious Ecthyma
12/2005
1Osteosarcoma (Osteogenic Sarcoma)
03/2005
1Esophageal Fistula
02/2005
1Cowpox
01/2005
1HIV Infections (HIV Infection)
01/2005
1Vaccinia
01/2005
1Smallpox (Variola)
11/2002
1Dehydration (Water Stress)
12/2001
1Papillomavirus Infections
09/2001
1Colonic Neoplasms (Colon Cancer)
05/2001
1Recurrent respiratory papillomatosis
02/2001
1Epidermodysplasia Verruciformis
02/2000

Drug/Important Bio-Agent (IBA)

15Cidofovir (Vistide)FDA Link
10/2018 - 02/2000
13Antiviral Agents (Antivirals)IBA
02/2015 - 01/2000
6NucleosidesIBA
02/2015 - 12/2001
4Acyclovir (Aciclovir)FDA LinkGeneric
03/2012 - 08/2000
3Tenofovir (Viread)FDA Link
02/2015 - 10/2004
3Organophosphonates (Phosphonates)IBA
02/2015 - 01/2005
3ProdrugsIBA
04/2013 - 08/2000
3Viral DNAIBA
01/2013 - 03/2005
3Thymidine KinaseIBA
01/2013 - 03/2004
3Pharmaceutical PreparationsIBA
06/2001 - 01/2000
2adefovirIBA
02/2015 - 10/2004
2EstersIBA
04/2013 - 03/2000
2Famciclovir (Famvir)FDA LinkGeneric
03/2012 - 08/2000
2penciclovir (Denavir)FDA Link
03/2012 - 08/2000
2Valacyclovir (Valtrex)FDA LinkGeneric
03/2012 - 08/2000
2CytosineIBA
05/2011 - 01/2005
2Ganciclovir (Cytovene)FDA LinkGeneric
03/2005 - 03/2000
2IronIBA
02/2001 - 11/2000
1Viral ProteinsIBA
02/2015
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
02/2015
1Attenuated VaccinesIBA
01/2013
1VaccinesIBA
01/2013
1brivudine (brivudin)IBA
03/2012
1diphosphoric acid (pyrophosphoric acid)IBA
03/2012
1FoscarnetFDA LinkGeneric
03/2012
1Deoxycytidine Monophosphate (DCMP)IBA
05/2011
1phosphoramidic acidIBA
01/2009
1pyridineIBA
06/2008
1Cytostatic AgentsIBA
06/2008
1Aligeron (AS 2)IBA
02/2005
1adefovir dipivoxil (Hepsera)FDA Link
01/2005
19- (S)- (3- hydroxy- 2- (phosphonomethoxy)propyl)adenineIBA
01/2005
1AdenineFDA LinkGeneric
01/2005
1alkoxyl radicalIBA
01/2005
19- (3- hydroxy- 2- phosphonomethoxypropyl)- 2,6- diaminopurineIBA
01/2005
16- phosphonylmethoxyethoxy- 2,4- diaminopyrimidineIBA
10/2004
1pyrimidineIBA
03/2004
1Biological ProductsIBA
12/2001
1Cyanides (Isocyanides)IBA
12/2001
13'- O- tert- butyldimethylsilyl- 2',5'- dideoxy- 5'- oxothymidineIBA
12/2001
1MagnesiumIBA
12/2001
1PotassiumIBA
12/2001
1benzeneselenolIBA
12/2001
1NucleotidesIBA
09/2001
1Isotretinoin (Accutane)FDA LinkGeneric
06/2001
1InterferonsIBA
06/2001
1AmidesIBA
05/2001
1ThiophenesIBA
05/2001
1cyclohexenyl-GIBA
04/2001
1Antineoplastic Agents (Antineoplastics)IBA
04/2001
1ClayIBA
02/2001
1SoilIBA
02/2001
1Chelating AgentsIBA
11/2000
1Deferoxamine (Desferal)FDA LinkGeneric
11/2000
1DeferiproneIBA
11/2000
1Fatty Acids (Saturated Fatty Acids)IBA
03/2000
1elaidic acidIBA
03/2000
1ganciclovir elaidateIBA
03/2000

Therapy/Procedure

3Therapeutics
01/2013 - 08/2000
1Stents
02/2005
1Drug Therapy (Chemotherapy)
04/2001
1Lasers (Laser)
02/2001
1Injections
01/2001